Catalent (CTLT) Misses Q3 EPS by 1c

Go back to Catalent (CTLT) Misses Q3 EPS by 1c

Catalent, Inc. Reports Third Quarter 2016 Results

May 4, 2016 4:17 PM EDT

Revenue decreased 2% as reported and increased 2% in constant currency to $438.0 million from third quarter 2015 Adjusted Net Income(1) totaled $25.0 million, or $0.20 per diluted share Full resolution of Beinheim facility license suspension; license reinstated April 28th, 2016

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the third quarter of fiscal year 2016, which... More